Clinical Trial Update: Civamide in OA of the Knee(s) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating civamide for knee osteoarthritis has completed. The sponsor is Winston Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Civamide (civamide)

Snippet

Sponsor: Winston Laboratories | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED